Chaos as £40million pilot scheme for Wegovy is delayed indefinitely due to unprecedented demand for 'game-changing' weight-loss jab

Chaos as £40million pilot scheme for Wegovy is delayed indefinitely due to unprecedented demand for 'game-changing' weight-loss jab A £40million pilot scheme at the heart of the Government's anti-obesity strategy has been delayed due to a major shortage of weight-loss jabs.

Ministers announced in June that GPs would supply semaglutide to tens of thousands of patients in a bid to improve their health and cut hospital waiting lists.

But soaring global demand for the drug — sold by Danish firm Novo Nordisk under the brand name Wegovy - has delayed both its launch on the NHS and the two-year programme indefinitely. The Daily Mail